IRIS
BAIOCCHI, LEONARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 32.236
AS - Asia 7.140
EU - Europa 3.133
SA - Sud America 711
Continente sconosciuto - Info sul continente non disponibili 568
AF - Africa 79
OC - Oceania 9
Totale 43.876
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 32.032
SG - Singapore 4.577
CN - Cina 960
BR - Brasile 548
RU - Federazione Russa 509
HK - Hong Kong 493
IT - Italia 488
VN - Vietnam 397
DE - Germania 375
UA - Ucraina 362
IE - Irlanda 343
GB - Regno Unito 228
SE - Svezia 192
BD - Bangladesh 189
FI - Finlandia 187
FR - Francia 155
JP - Giappone 112
KR - Corea 104
IN - India 90
CA - Canada 86
PL - Polonia 72
AR - Argentina 56
MX - Messico 49
AT - Austria 41
NL - Olanda 41
ID - Indonesia 32
CO - Colombia 30
ES - Italia 29
IQ - Iraq 26
ZA - Sudafrica 26
BE - Belgio 25
EC - Ecuador 23
JM - Giamaica 18
TR - Turchia 18
VE - Venezuela 18
EG - Egitto 15
PK - Pakistan 15
CH - Svizzera 13
CL - Cile 12
CR - Costa Rica 12
IL - Israele 12
LT - Lituania 12
MA - Marocco 12
UZ - Uzbekistan 12
SA - Arabia Saudita 11
CZ - Repubblica Ceca 10
HN - Honduras 10
EU - Europa 9
MY - Malesia 9
PY - Paraguay 9
AE - Emirati Arabi Uniti 8
AU - Australia 8
KE - Kenya 8
TH - Thailandia 8
TT - Trinidad e Tobago 8
JO - Giordania 7
KZ - Kazakistan 7
RO - Romania 7
PE - Perù 6
PH - Filippine 6
UY - Uruguay 6
AL - Albania 5
IR - Iran 5
PT - Portogallo 5
TN - Tunisia 5
BB - Barbados 4
BH - Bahrain 4
DO - Repubblica Dominicana 4
LV - Lettonia 4
NO - Norvegia 4
NP - Nepal 4
OM - Oman 4
SK - Slovacchia (Repubblica Slovacca) 4
TM - Turkmenistan 4
AZ - Azerbaigian 3
DZ - Algeria 3
GR - Grecia 3
KG - Kirghizistan 3
LB - Libano 3
NI - Nicaragua 3
PS - Palestinian Territory 3
SV - El Salvador 3
TW - Taiwan 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CY - Cipro 2
DK - Danimarca 2
ET - Etiopia 2
HR - Croazia 2
KH - Cambogia 2
KN - Saint Kitts e Nevis 2
KW - Kuwait 2
NG - Nigeria 2
RS - Serbia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
Totale 43.299
Salva come PNG Salva come JPEG
Città #
Woodbridge 7.910
Wilmington 7.527
Houston 6.702
Singapore 1.272
Fairfield 1.026
Ashburn 766
San Jose 691
Ann Arbor 667
Hong Kong 485
Seattle 452
Chandler 444
New York 393
Beijing 371
Cambridge 371
Jacksonville 327
Dublin 311
Council Bluffs 273
Medford 249
Santa Clara 206
Los Angeles 174
Dearborn 167
Rome 155
Ho Chi Minh City 146
The Dalles 141
Lawrence 118
Helsinki 101
Tokyo 100
Buffalo 99
San Diego 92
Elk Grove Village 88
Hanoi 87
Menlo Park 69
Lauterbourg 62
Moscow 62
São Paulo 57
Zhengzhou 57
Dallas 56
Mülheim 52
Orem 50
Milan 49
Boardman 43
Atlanta 41
Chicago 40
Frankfurt am Main 37
London 37
Seoul 36
Munich 35
Nuremberg 32
Warsaw 31
Brooklyn 30
North Bergen 26
Chennai 25
Montreal 24
Palo Alto 24
Denver 23
Falls Church 23
Redwood City 23
Shanghai 23
Kraków 22
Mexico City 22
Norwalk 21
Brussels 19
Manchester 19
San Francisco 19
Johannesburg 18
Stockholm 18
Vienna 18
Nanjing 17
Phoenix 17
Washington 17
Redondo Beach 16
San Mateo 16
Toronto 16
University Park 16
Colorado Springs 15
Creede 15
Miami 15
Rio de Janeiro 15
Belo Horizonte 14
Da Nang 14
Jakarta 14
Mountain View 14
Verona 14
Columbus 13
Guangzhou 13
Hefei 13
Jersey City 13
Lappeenranta 13
Mumbai 13
Naples 13
Paris 13
Philadelphia 13
Amsterdam 12
Chandigarh 12
Dhaka 12
Biên Hòa 11
Curitiba 11
Haiphong 11
Saint Petersburg 11
Tashkent 11
Totale 33.607
Salva come PNG Salva come JPEG
Nome #
Hepatitis C reinfection after liver transplantation in relation to virus genotype 619
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 582
Regression of cholangiocyte proliferation after cessation of ANIT feeding is coupled with increased apoptosis. 569
Tauroursodeoxycholate reduces ischemic damage in human allografts: a biochemical and ultrastructural study 560
Gastrin inhibits cholangiocarcinoma growth through increased apoptosis by activation of Ca2+-dependent protein kinase C-alpha. 557
Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. 540
Successful management of a same-day emergency delivery and liver transplant in a 27 weeks pregnant woman with fulminant hepatic failure. 508
Cyclosporine A versus tacrolimus monotherapy. Comparison on bile lipids in the first 3 months after liver transplant in humans 505
Bile acid depletion and repletion regulate cholangiocyte growth and secretion by a phosphatidylinositol 3-kinase-dependent pathway in rats. 504
An unusual endoscopic finding in a patient with melena: Multiple gastric ulcers of regular shape 494
Ab initio calcineurin inhibitor-based monotherapy immunosuppression after liver transplantation reduces the risk for Pneumocystis jirovecii pneumonia. 492
Taurocholate prevents the loss of intrahepatic bile ducts due to vagotomy in bile duct-ligated rats 482
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 482
Primary yolk sac tumor of the liver: incidental finding in a patient transplanted for hepatocellular carcinoma 478
Lamellar bodies coexist with vesicles and micelles in human gallbladder bile. Ursodeoxycholic acid prevents cholesterol crystal nucleation by increasing biliary lamellae 478
Relationship between GH/IGF-1 Axis, graft recovery, and early survival in patients undergoing liver transplantation 477
Correlation between liver fibrosis and inflammation in patients transplanted for HCV liver disease 474
Taurohyodeoxycholate- and tauroursodeoxycholate-induced hypercholeresis is augmented in bile duct ligated rats 469
596 467
Leptin attenuates ischemia-reperfusion injury in the rat liver. 463
Comment on the PROVE1 and PROVE2 clinical trials: "I was taking a picture of Rapid Virological Response with telaprevir, but the background is unfocused!". 462
A pilot study on the safety and effectiveness of immunosuppression without prednisone after liver transplantation 460
Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha 459
Assembly of biliary lipids in native hepatic bile after orthotopic liver transplantation: a biochemical and ultra-structural study in humans 457
Cholinergic system modulates growth, apoptosis, and secretion of cholangiocytes from bile duct-ligated rats. 457
Switch to 1.5 grams MMF monotherapy for CNI-related toxicity in liver transplantation is safe and improves renal function, dyslipidemia, and hypertension 456
N-ethyl-tauroursodeoxycholic acid, a novel deconjugation-resistant bile salt analogue: effects of acute feeding in the rat 454
Pitfalls in the reporting of upper endoscopy features in cirrhotic patients 453
The interplay between mast cells, pineal gland, and circadian rhythm: Links between histamine, melatonin, and inflammatory mediators 452
Physical examination of the liver: Does it make sense in the third millennium? 451
Bile acid feeding induces cholangiocyte proliferation and secretion: evidence for bile acid-regulated ductal secretion. 450
Evidence of Spontaneous Post-transplant HCV Eradication in Two Failed DAA Treatments Awaiting Liver Transplantation 450
Plasma/erythrocyte ribavirin x100 ratio as an indicator of sustained virological response in HCV genotype 1 patients with early virological response 449
Complete hbv prophylaxis withdrawal in HBsAg-positive liver transplant recipients after long-term minimal immunosuppression 447
Estrogens stimulate proliferation of intrahepatic biliary epithelium in rats. 446
Gastrin inhibits cholangiocyte growth in bile duct-ligated rats by interaction with cholecystokinin-B/Gastrin receptors via D-myo-inositol 1,4,5-triphosphate-, Ca(2+)-, and protein kinase C alpha-dependent mechanisms. 445
Sequential changes in serum and biliary bile acids after liver transplantation 443
Dissolution of human cholesterol gallstones in bile salt/lecithin mixtures: effect of bile salt hydrophobicity and various pHs 443
One-year pilot study on tauroursodeoxycholic acid as an adjuvant treatment after liver transplantation 442
Reduced acute rejection and side effects with neoral in liver transplantation. 441
A survey on mortality from non-variceal upper gastrointestinal bleeding: Is the emergency referral system adequate? 440
Immunosuppression-Free Liver Transplantation 439
Liver transplantation for end-stage liver disease related to viral hepatitis 438
TUDCA prevents cholestasis and canalicular damage induced by ischemia-reperfusion injury in the rat, modulating PKC alpha-ezrin pathway 438
Qualitative patterns of biliary bile acids affect cyclosporine intestinal absorption in liver transplant recipients 436
The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: the updated follow up at 78 months. 435
Bile acids with differing hydrophilic-hydrophobic properties do not influence cytokine production by human monocytes and murine Kupffer cells 432
Immunosuppression without prednisone after liver transplantion is safe and associated with normal early graft function: preliminary results of a randomized study 432
Patterns of bile salts and biliary lipids early after liver transplantation differentiate patients with unfavorable graft outcome. 426
Regulation of cholangiocyte bile secretion. 425
The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10-year follow-up 425
Different expression of VEGF and EGFL7 in human hepatocellular carcinoma 424
Non-transplant surgical approach to liver-based hereditary haemorrhagic telangiectasia: a first report 423
Protective role of tauroursodeoxycholate during harvesting and cold storage of human liver: a pilot study in transplant recipients. 420
Short-Term, Low-Dose Use of Tolvaptan as a Bridge Therapy to Expedite Liver Transplant for Severe Hyponatremic, Cirrhotic Patients With High Model for End-Stage Liver Disease Scores 419
Composition and aggregational forms of biliary lipids in human bile after short-term administration of Taurohyodeoxycholic acid 417
Hepatic steatosis: a specific sign of hepatitis C reinfection after liver transplantation 416
Prevention of hepatitis C recurrence after liver transplantation: An update. 415
Interferon-alpha treatment of hepatitis D induces tuberculosis exacerbation in an immigrant 413
Liver transplantation for hepatitis C virus end-stage liver cirrhosis as compared with other nonviral indications 411
Plasma clearance of cholyl-lysyl-fluorescein: a pilot study in humans. 407
Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductule fragments and isolated perfused rat liver. 407
Cholangiocarcinoma: Challenges and future needs 406
Randomized study on in situ liver perfusion techniques: gravity perfusion vs high-pressure perfusion 404
Effect of taurohyodeoxycholic acid on biliary lipid secretion in man: preliminary report 397
Effect of taurohyodeoxycholic acid, a hydrophilic bile salt, on bile salt and biliary lipid secretion in the rat 397
Secretin activation of the apical Na+-dependent bile acid transporter is associated with cholehepatic shunting in rats. 389
Oral S-adenosyl-L-methionine (SAMe) administration enhances bile salt conjugation with taurine in patients with liver cirrhosis 383
Acute carbon tetrachloride feeding selectively damages large, but not small, cholangiocytes from normal rat liver. 382
Standard bowel cleansing is highly ineffective in cirrhotic patients undergoing screening colonoscopy 382
Ab initio Everolimus-based Versus Standard Calcineurin Inhibitor Immunosuppression Regimen in Liver Transplant Recipients 378
An unusual duodenal polyp causing anemia in a liver-transplanted patient 351
Tips for TIPS: A combined percutaneous and transjugular approach for intrahepatic portosystemic shunt placement after liver transplant 346
Importance of liver biopsy findings in immunosuppression management: Biopsy monitoring and working criteria for patients with operational tolerance (OT) 345
Clinical Operational Tolerance and Immunosuppression Minimization in Kidney Transplantation: Where Do We Stand? 345
Longterm Survival and Cost-Effectiveness of Immunosuppression Withdrawal After Liver Transplantation 338
Hepatitis B virus recurrence after liver transplantation: An old tale or a clear and present danger? 336
Neuroendocrine Changes in Cholangiocarcinoma Growth 307
Pro-inflammatory signalling and gut-liver axis in non-alcoholic and alcoholic steatohepatitis: differences and similarities along the path 302
Renal Function, Adherence and Quality of Life Improvement After Conversion From Immediate to Prolonged-Release Tacrolimus in Liver Transplantation: Prospective Ten-Year Follow-Up Study 283
Feedback signaling between cholangiopathies, ductular reaction, and non-alcoholic fatty liver disease 283
Management of cholangiocarcinoma in the third millennium: time to be guided! 272
Dual role of bile acids on the biliary epithelium: Friend or foe? 255
The Dynamic Interplay Between Mast Cells, Aging/Cellular Senescence, and Liver Disease 249
Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer 217
Domino liver transplantation: Where are we now? 215
Liver transplantation for hepatocellular carcinoma: Where do we stand? 211
Possible application of melatonin treatment in human diseases of the biliary tract 210
Current Advances in Basic and Translational Research of Cholangiocarcinoma 210
De novo malignancies after liver transplantation: The effect of immunosuppression-personal data and review of literature 209
Liver transplantation in a patient with complete portal vein thrombosis, is there a surgical way out? A case report 203
Healthy peribiliary glands are necessary for successful liver transplantation 186
Knockdown of vimentin reduces mesenchymal phenotype of cholangiocytes in the Mdr2−/− mouse model of primary sclerosing cholangitis (PSC) 162
Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis 158
Cholangiocarcinoma: Bridging the translational gap from preclinical to clinical development and implications for future therapy 154
2016 comprehensive update of the Banff working group on liver allograft pathology: Introduction of antibody-mediated rejection 153
Moving forward in the treatment of cholangiocarcinoma 133
Serum Levels of Granulocyte-Macrophage-colony-stimulating Factor and Stem-cell Factor During Liver Regeneration after Partial Hepatectomy in Humans 122
Kupffer Cells: Inflammation Pathways and Cell-Cell Interactions in Alcohol-Associated Liver Disease 122
Organoids and spheroids as novel models for studying cholestatic liver injury and cholangiocarcinoma 122
Totale 38.872
Salva come PNG Salva come JPEG
Categoria #
all - tutte 113.811
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 113.811
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.221 0 0 100 80 33 223 65 69 106 133 75 337
2022/20231.375 154 111 33 135 126 295 150 91 126 22 100 32
2023/2024537 60 16 61 7 110 108 22 18 11 39 3 82
2024/20255.573 87 752 391 173 34 310 291 140 335 196 1.629 1.235
2025/20266.664 595 247 623 624 563 428 806 776 798 640 301 263
2026/20271.490 541 569 380 0 0 0 0 0 0 0 0 0
Totale 43.876